摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

distearoylamine | 4372-87-6

中文名称
——
中文别名
——
英文名称
distearoylamine
英文别名
N-Octadecanoyloctadecanamide
distearoylamine化学式
CAS
4372-87-6
化学式
C36H71NO2
mdl
——
分子量
549.965
InChiKey
MFPOQHJDIPCXSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    16.1
  • 重原子数:
    39
  • 可旋转键数:
    32
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    46.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    distearoylamine丙烯酸甲酯(MA) 以42 %的产率得到methyl N,N-dioctadecyl-3-aminopropanoate
    参考文献:
    名称:
    [EN] IONIZABLE LIPIDS AND LIPID NANOPARTICLES COMPRISING SAID IONIZABLE LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS
    [FR] LIPIDES IONISABLES ET NANOPARTICULES LIPIDIQUES COMPRENANT LESDITS LIPIDES IONISABLES POUR L'ADMINISTRATION D'AGENTS THÉRAPEUTIQUES
    摘要:
    A novel class of ionizable lipid compounds as well as lipid nanoparticles comprising said ionizable lipid compounds is provided. Advantageously, upon hydrolysis of an internal ester bond, which is likely to occur under typical in vivo conditions, a zwitterionic lipid structure is obtained, which is no longer capable of complexing a nucleic acid, which will thus be released from the lipid nanoparticle and subsequently is able to perform its therapeutic function.
    公开号:
    WO2022207938A1
  • 作为产物:
    描述:
    十八烷酰氯硬脂酰胺 140.0 ℃ 、1.33 kPa 条件下, 生成 distearoylamine
    参考文献:
    名称:
    Preparation of the higher monoacylamides from monoamides and acid halides
    摘要:
    公开号:
    US02672470A1
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS<br/>[FR] NOUVEAUX LIPIDES ET FORMULATIONS NANOPARTICULAIRES LIPIDIQUES POUR L'ADMINISTRATION D'ACIDES NUCLÉIQUES
    申请人:ACUITAS THERAPEUTICS INC
    公开号:WO2015199952A1
    公开(公告)日:2015-12-30
    Compounds are provided having the following structure: (I) or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1a, R1b, R2a, R2b, R3a, R3b, R4a, R4b, R5, R6, R7, R8, R9, L1, L2, a, b, c, d and e are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
    提供具有以下结构的化合物:(I)或其药用盐、互变异构体或立体异构体,其中R1a、R1b、R2a、R2b、R3a、R3b、R4a、R4b、R5、R6、R7、R8、R9、L1、L2、a、b、c、d和e的定义如本文所述。还提供了将这些化合物用作脂质纳米粒子制剂的组分、包含这些化合物的组合物以及其使用和制备方法。
  • Thermostable hydrolase
    申请人:Gruning Burghard
    公开号:US20050112644A1
    公开(公告)日:2005-05-26
    The present invention relates to a newly identified hydrolase from thermophilic microorganisms having thermostable properties, and more specifically, to a novel thermostable hydrolase showing high activity at high temperatures.
    本发明涉及一种新鉴定的热嗜微生物水解酶,具有热稳定性质,更具体地,涉及一种新型高温活性的热稳定水解酶。
  • Production of carboxylic acid and carbonic acid derivatives using a thermostable esterase
    申请人:Gruning Burghard
    公开号:US20060008887A1
    公开(公告)日:2006-01-12
    The present invention relates to processes for the production of acyl compounds using an esterase having thermostable properties, and to products of such processes.
    本发明涉及使用具有热稳定性的酯酶生产酰基化合物的工艺,以及该工艺的产品。
  • NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS
    申请人:Acuitas Therapeutics Inc.
    公开号:US20150376115A1
    公开(公告)日:2015-12-31
    Compounds are provided having the following structure: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R 1a , R 1b , R 2a , R 2b , R 3a , R 3b , R 4a , R 4b , R 5 , R 6 , R 7 , R 8 , R 9 , L 1 , L 2 , a, b, c, d and e are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.
    提供具有以下结构的化合物:其中R1a,R1b,R2a,R2b,R3a,R3b,R4a,R4b,R5,R6,R7,R8,R9,L1,L2,a,b,c,d和e的药物可接受的盐,互变异构体或立体异构体,如此处所定义。还提供将该化合物用作脂质纳米粒子配方的组分,用于传递治疗剂的组成物以及其使用和制备方法。
  • Synthetic rubber bale wrap
    申请人:EXXON CHEMICAL PATENTS INC.
    公开号:EP0345927A2
    公开(公告)日:1989-12-13
    A film for use as a rubber bale wrap includes a thermoplastic containing a release agent and having a microembossed surface to provide the film with a gloss of 10 or less.
    一种用作橡胶包膜的薄膜包括一种含有脱模剂的热塑性塑料,其表面经过微压花处理,使薄膜的光泽度达到或低于 10。
查看更多